domingo, 28 de septiembre de 2025

First brain-delivered AAV therapy approved by FDA The gene therapy treats the rare genetic disease AADC deficiency by delivering a functional gene into the brain.

https://www.drugdiscoverynews.com/first-brain-delivered-aav-therapy-approved-by-fda-16214?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9zvfPLFVCUgoktj5NuAZYyUgeWjIwIDx8UMh8woVe1sNQdPQjRnXADT9y-nojgZpKdZQAho1sDlgjm6tfmve090BuvFQ&_hsmi=382421970&utm_content=382421970&utm_source=hs_email

No hay comentarios:

Publicar un comentario